Arkadios Wealth Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
Other funds holding SNDX
APM
NCM
FM
ACA
PHS
BI
Arkadios Wealth Advisors's SNDX Position: Q4 2021 in Review
Arkadios Wealth Advisors sold out of Syndax Pharmaceuticals (SNDX) in Q4 2021, closing a stake of 510 shares — an estimated $9K sold.
Arkadios Wealth Advisors first reported a position in SNDX in Q2 2020 and held it in 6 quarters. The position peaked at $24.6K in Q2 2020. 132 funds tracked by Wall St. Rank hold SNDX as of Q4 2021.
- Arkadios Wealth Advisors reported no remaining Syndax Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
- Arkadios Wealth Advisors sold 510 Syndax Pharmaceuticals shares in Q4 2021, an estimated $9K.
- Arkadios Wealth Advisors first reported a position in Syndax Pharmaceuticals in Q2 2020 and held it in 6 quarters.
- Arkadios Wealth Advisors's Syndax Pharmaceuticals position peaked at $24.6K in Q2 2020.
- 132 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2021.
Based on Arkadios Wealth Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.